Acrux Limited (ASX:ACR)
Australia · Delayed Price · Currency is AUD 0.0110
+0.0010 (10.00%)
Oct 9, 2026, 4:10 PM AEST
Acrux Market Cap
Acrux has a market cap or net worth of 6.49 million as of October 9, 2026. It is the 45,421st most valuable company in the world and the 1,480th biggest in Australia. Its market cap has increased by 13.21% in one year.
Market Cap
6.49M
Enterprise Value
7.30M
Revenue
6.58M
Global Rank
Country Rank
#1,480 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 29, 2004, Acrux's market cap has decreased from 90.77M to 6.49M, a decrease of -92.85%. That is a compound annual growth rate of -11.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 6.49M | 5.31% |
| Dec 31, 2025 | 6.16M | -53.60% |
| Dec 31, 2024 | 13.27M | 4.16% |
| Dec 29, 2023 | 12.74M | -36.43% |
| Dec 30, 2022 | 20.05M | -29.33% |
| Dec 31, 2021 | 28.37M | -18.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 14.53M |
| AdAlta | 11.24M |
| Invex Therapeutics | 8.27M |
| Vectus Biosystems | 6.53M |
| Bio-Gene Technology | 6.13M |
| Zelira Therapeutics | 5.95M |
| Biotron | 5.57M |
| Tissue Repair | 5.14M |